Sarepta Therapeutics (SRPT) Free Cash Flow (QoQ) (2010 - 2026)
Sarepta Therapeutics (SRPT) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Sarepta Therapeutics | 1.71 Bn | 1.31 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -260.45% |
| Dec 31, 2025 | 440.13% |
| Sep 30, 2025 | -116.35% |
| Jun 30, 2025 | 136.60% |
| Mar 31, 2025 | -1,262.05% |
| Dec 31, 2024 | 149.98% |
| Sep 30, 2024 | -658.96% |
| Jun 30, 2024 | 94.82% |
| Mar 31, 2024 | -272.50% |
| Dec 31, 2023 | 48.96% |
| Sep 30, 2023 | -3.02% |
| Jun 30, 2023 | 35.97% |
| Mar 31, 2023 | -118.10% |
| Dec 31, 2022 | -37.11% |
| Sep 30, 2022 | 3.56% |
| Jun 30, 2022 | 28.89% |
| Mar 31, 2022 | -238.47% |
| Dec 31, 2021 | 76.39% |
| Sep 30, 2021 | -16.11% |
| Jun 30, 2021 | 42.91% |